Received
Monday, December 20, 2021
Commodity
Monomer-Dimer Hybrid Immunoconjugates
Investigation Number
Withdrawn
Filed By
Scott K. Reed
Firm/Organization
Venable LLP
Behalf Of
Bioverativ Therapeutics Inc., Genzyme Corporation, Genzyme Europe B.V., Bioverativ U.S. LLC, and Bioverativ Pacific LLC
Confidential
Yes
Country
None
Description
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain monomer-dimer hybrid immunoconjugates. The proposed respondents are Hanmi Pharmaceutical Co., Ltd., Korea; and Spectrum Pharmaceuticals, Inc., Henderson, NV.

Petition/Complaint Status
Withdrawn